Ixico Share News (IXI)

IXICO Joins Medical Research Council Collaboration For Dementia Drive

LONDON (Alliance News) - IXICO PLC said Thursday it will take part in a GBP16 million collaboration launched by publicly funded government agency the Medical Research Council to speed up research into dementia. The MRC has launched the UK Dementias Research Platform with the aim of seeking

Ixico partners with the Medical Research Council to launch UK Dementias Research Platform

Biotechnology group Ixico has partnered with the Medical Research Council (MRC) to launch the UK Dementias Research Platform (UKDP), a £16m public-private partnership. The group, which set up the partnership to speed up research into dementias, will act as the MRC's imaging partner on the project a

IXICO To Meet Full-Year Expectations As Interim Hit By Listing Costs

LONDON (Alliance News) - IXICO PLC expressed confidence Friday in meeting market expectations for the full year, as it swung into a loss in the half year to end-March, hit by costs relating to its AIM listing and a decline in revenues. The company was formed via the reverse takeover of Phyt

IXICO Wins Contracts For Huntington's Disease Clinical Trials

LONDON (Alliance News) - Brain health company IXICO PLC Thursday said it has won contracts for two separate clinical trials in Huntington's disease with "top 15" pharmaceutical companies, building on a third clinical study already underway on the disease. In a statement, IXICO said the two

IXICO Awarded Development Contract By NHS England Initiative

LONDON (Alliance News) - IXICO PLC Wednesday said it has been awarded a development contract by The Small Business Research Initiative for Healthcare, an NHS England initiative, to cover phase 1 funding for the development of an online application designed to support dementia sufferers after they

UK MORNING BRIEFING: RSA Loses UK & Western Europe Chief Executive

LONDON (Alliance News) - RSA Insurance Group said Wednesday the Chief Executive of the business which houses its troubled Irish operations has resigned in order to become Executive Chairman, underwriting and distribution, at business partner A J.Gallagher. The company said UK & Western Euro

Thursday broker round-up UPDATE

Antofagasta: Deutsche Bank cuts target price from 770p to 735p and downgrades to sell. Investec cuts target price from 753p to 726p keeping its sell recommendation. Ashmore Group: HSBC Holdings lowers target price from 410p to 400p retaining its overweight rating. Avacta Group: Numis shifts target

Standard Chartered non-exec builds company holding after profit decline

An Independent Non-Executive Director of Standard Chartered has this week upped his stake in the group by a quarter with the purchase of 2,500 shares. John Paynter, who was appointed to his role in 2008, bought the shares at 1,246.50p each for a total of £31,163, taking his total holding to 12,50

DIRECTOR DEALINGS: Ixico Non-Executives Buy Shares

LONDON (Alliance News) - Ixico PLC said Tuesday that non-executive chairman Andy Richards had bought 13,700 shares at 78 pence each. Non-executive director Tim Sharpington bought 12,750 shares at 78.5 pence also on Tuesday. Following these purchases Richards has a 0.2% interest in the

IXICO, VirtualScopics In International Commercial, Operational Alliance

LONDON (Alliance News) - Brain health company IXICO PLC Friday said it has entered into an international commercial and operational alliance with VirtualScopics Inc, a quantitative medical imaging provider. "The proposed alliance will provide the clinical trials industry with global operati

IXICO Positive On Position Following Business Transition

LONDON (Alliance News) - IXICO PLC, the company formed when IXICO Ltd and Phytopharm PLC merged, said Friday that it believes it is strongly positioned in its core clinical trials and experimental medicine markets following the transition of its business. The company formally known as Phyto

DIRECTOR DEALINGS: IXICO Non-Executive Director Buys Shares

IXICO Non-Executive Director Buys Shares

DIRECTOR DEALINGS: Ixico Executive Buys Shares

DIRECTOR DEALINGS: IXICO CEO Buys 4,000 Shares